Françoise Bachelerie

7PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 12, 2025
A circadian checkpoint relocates neutrophils to minimize injury.

Alejandra Aroca-Crevillén, Sandra Martín-Salamanca, Lidiane S Torres

|Oct 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Vincent Rondeau, Maria Kalogeraki, Lilian Roland

|Feb 15, 2022
The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Géraldine Schlecht-Louf, Claire Deback, Françoise Bachelerie

|Nov 27, 2021
Multi-Tissue Characterization of GILZ Expression in Dendritic Cell Subsets at Steady State and in Inflammatory Contexts.

Molène Docq, Mathias Vétillard, Carmen Gallego

|Jan 20, 2021
The G Protein-Coupled Receptor Kinases (GRKs) in Chemokine Receptor-Mediated Immune Cell Migration: From Molecular Cues to Physiopathology.

Marta Laganà, Géraldine Schlecht-Louf, Françoise Bachelerie

|May 07, 2020
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.

Agnieszka Jaracz-Ros, Guillaume Bernadat, Pasquale Cutolo

Pageof 2

Frequent Collaborators

4 joint publications

Géraldine Schlecht-Louf

3 joint publications

Karl Balabanian

2 joint publications

Carmen Gallego

1 joint publications

Joyce Koenen